Monday, November 18, 2013

$2.2 Billion J&J/Risperdal Settlement: Only The Beginning

via Mad in America;
$2.2 Billion Settlement: Only The Beginning

November 15, 2013

At least 250 lawsuits involving Johnson & Johnson’s improper marketing of Risperdal are pending in Pennsylvania’s Philadelphia Court of Common Pleas, according to information provided by a law firm involved in the litigation.  The firm, which represents individuals who may have developed gynecomastia (male breast growth) as a result of the drug, alleges that the unapproved use of Risperdal to treat ADHD is also on the rise.
Further reading:Antipsychotic Risperdal Slapped with $2 Billion Dementia Penalty (Alzheimer’s & Dementia Weekly)

Thank You Mr Cole, and MIA.
Read more:
  • State AGs (15)
  • pic cred to MIA

  • No comments: